Pemetrexed
Sold as Alimta, Lilly pemetrexed, Key pemetrexed, SPEC pemetrexed, Pemetrexed accord, Terexta, Pemetrexed cipla, Pemalimta, Pexali, Aliloma, Maligta, Natpem, Genpetrex, Luprexta, Peminjo inj, Malihet, Pesodin
(2S)-2-[[4-[2-(2-Amino-4-oxo-3,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid
Drag to rotate. Structure from PubChem CID 135410875.
Background
Registration
- Applicants
- 12
- Registrations
- 37
- Schedule source
- Consolidated Schedules 06 July 2026
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Eli Lilly (S.A.) (Pty) Ltd1 of 4 cancelled | Alimta, Lilly pemetrexed | 100 mg, 500 mg | 420448, 450038, 450039, A390028 | S4 | None |
| Key Oncologics (Pty) LtdCancelled | Key pemetrexed | 500 mg | 470587 | S4 | None |
| Specpharm (Pty) Ltd | SPEC pemetrexed | 1 000, 100, 500 | 490729, 490730, 490731 | S4 | None |
| Accord Healthcare (Pty) Ltd1 of 4 cancelled | Pemetrexed accord, Terexta | 100, 500 | 490888, 490889, 521002, 521003 | S4 | None |
| Cipla Medpro (Pty) LtdCancelled | Pemetrexed cipla, Pemalimta | 100, 500 | 510242, 510243, 510244.242, 510245.243 | S4 | None |
| Macleods Pharmaceuticals SA (Pty) LtdCertificate held by Abex Pharmaceutica (Pty) Ltd | Pexali | 100, 500 | 510518.516, 510519.517 | S4 | PIPIL |
| Kcp Products CCCertificate held by Kahma Biotech (Pty) Ltd | Aliloma | 100mg/ 500mg | 530564 | S4 | PIPIL |
| Juno Pharma SA (Pty) LtdCertificate held by Kahma Biotech (Pty) Ltd | Aliloma | 100mg/ 500mg | 530565 | S4 | PIPIL |
| Innovata pharmaceuticals | Maligta | 100, 500 | 550904, 550905 | S4 | None |
| Adcock ingram limited | Natpem | 1 000, 100, 500 | 560053, 560054, 560055 | S4 | None |
| Aurogen South Africa (Pty) Ltd | Genpetrex, Luprexta | 000 mg 1, 100 mg, 500 mg | 560197, 560198, 560199, 560200.197, 560201.198, 560202.199 | S4 | None |
| Hetero Drugs South Africa (Pty) Ltd | Peminjo inj, Malihet, Pesodin | 100, 500 | 560434, 560435, 560436.434, 560437.435, 560438.434, 560439.435 | S4 | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Alimta 100 MG EACH VIAL CONTAINS PEMETREXED SODIUM EQUIVALENT TO PEMETREXED 100,0 mg | 100 mg | 42044842/26/0448 | Cancelled | S4 | None |
| Lilly pemetrexed 100 MG EACH VIAL CONTAINS PEMETREXED SODIUM 100,0 mg | 100 mg | 45003845/26/0038 | Registered | S4 | None |
| Lilly pemetrexed 500 EACH VIAL CONTAINS PEMETREXED SODIUM 500,0 mg | 500 | 45003945/26/0039 | Registered | S4 | None |
| Key pemetrexed 500 MG Each Vial contains: Pemetrexed Disodium Hemipentahydrate equivalent to Pemetrexed 500,0 mg | 500 mg | 47058747/26/0587 | Cancelled | S4 | None |
| SPEC pemetrexed 100 EACH VIAL CONTAINS : PEMETREXED SODIUM EQUIVALENT TO PEMETREXED 100,0 mg | 100 | 49072949/26/0729 | Registered | S4 | None |
| SPEC pemetrexed 500 EACH VIAL CONTAINS : PEMETREXED SODIUM EQUIVALENT TO PEMETREXED 500,0 mg | 500 | 49073049/26/0730 | Registered | S4 | None |
| SPEC pemetrexed 1 000 EACH VIAL CONTAINS : PEMETREXED SODIUM EQUIVALENT TO PEMETREXED 1 000,0 mg | 1 000 | 49073149/26/0731 | Registered | S4 | None |
| Pemetrexed accord 500 EACH VIAL CONTAINS PEMETREXED SODIUM EQUIVALENT TO PEMETREXED 500,0 mg | 500 | 49088849/26/0888 | Registered | S4 | None |
| Terexta 500 EACH VIAL CONTAINS PEMETREXED SODIUM EQUIVALENT TO PEMETREXED 500,0 mg | 500 | 49088949/26/0889 | Registered | S4 | None |
| Pemetrexed cipla 100 EACH VIAL CONTAINS PEMETREXED SODIUM EQUIVALENT TO PEMETREXED 100,0 mg | 100 | 51024251/26/0242 | Cancelled | S4 | None |
| Pemetrexed cipla 500 EACH VIAL CONTAINS PEMETREXED SODIUM EQUIVALENT TO PEMETREXED 500,0 mg | 500 | 51024351/26/0243 | Cancelled | S4 | None |
| Pemalimta 100 EACH VIAL CONTAINS PEMETREXED SODIUM EQUIVALENT TO PEMETREXED 100,0 mg | 100 | 510244.24251/26/0244.242 | Cancelled | S4 | None |
| Pemalimta 500 EACH VIAL CONTAINS PEMETREXED SODIUM EQUIVALENT TO PEMETREXED 500,0 mg | 500 | 510245.24351/26/0245.243 | Cancelled | S4 | None |
| Pexali 100 | 100Powder for concentrate for solution for infusion. | 510518.51651/26/0518.516Approved 30 May 2023 | Registered | S4 | PIPIL |
| Pexali 500 | 500Powder for concentrate for solution for infusion. | 510519.51751/26/0519.517Approved 30 May 2023 | Registered | S4 | PIPIL |
| Pemetrexed accord 100 EACH VIAL CONTAINS PEMETREXED SODIUM EQUIVALENT TO PEMETREXED 100,0 mg | 100 | 52100252/26/1002 | Registered | S4 | None |
| Terexta 100 Each Vial contains: Pemetrexed Disodium equivalent to Pemetrexed 100,0 mg | 100 | 52100352/26/1003 | Cancelled | S4 | None |
| Aliloma 100 EACH VIAL CONTAINS PEMETREXED SODIUM EQUIVALENT TO PEMETREXED 100,0 mg | 100mg/ 500mgPowder for solution for infusion | 53056453/26/0564Approved 19 October 2021 | Registered | S4 | PIPIL |
| Aliloma 500 EACH VIAL CONTAINS PEMETREXED SODIUM EQUIVALENT TO PEMETREXED 500,0 mg | 100mg/ 500mgPowder for solution for infusion | 53056553/26/0565Approved 19 October 2021 | Registered | S4 | PIPIL |
| Maligta 100 EACH VIAL CONTAINS PEMETREXED 100,0 mg | 100 | 55090455/26/0904 | Registered | S4 | None |
| Maligta 500 EACH VIAL CONTAINS PEMETREXED 500,0 mg | 500 | 55090555/26/0905 | Registered | S4 | None |
| Natpem 100 EACH VIAL CONTAINS PEMETREXED 100,0 mg | 100 | 56005356/26/0053 | Registered | S4 | None |
| Natpem 500 EACH VIAL CONTAINS PEMETREXED 500,0 mg | 500 | 56005456/26/0054 | Registered | S4 | None |
| Natpem 1 000 EACH VIAL CONTAINS PEMETREXED 1 000,0 mg | 1 000 | 56005556/26/0055 | Registered | S4 | None |
| Genpetrex 100 mg/vial EACH VIAL CONTAINS PEMETREXED DISODIUM HEMIPENTAHYDRATE EQUIVALENT TO PEMETREXED 100,0 mg | 100 mg/Vial | 56019756/26/0196 | Registered | S4 | None |
| Genpetrex 500 mg/vial EACH VIAL CONTAINS PEMETREXED DISODIUM HEMIPENTAHYDRATE EQUIVALENT TO PEMETREXED 500,0 mg | 500 mg/Vial | 56019856/26/0198 | Registered | S4 | None |
| Genpetrex 1 000 mg/vial EACH VIAL CONTAINS PEMETREXED DISODIUM HEMIPENTAHYDRATE EQUIVALENT TO PEMETREXED 1 000,0 mg | 000 mg 1/Vial | 56019956/26/0199 | Registered | S4 | None |
| Luprexta 100 mg/vial EACH VIAL CONTAINS PEMETREXED DISODIUM HEMIPENTAHYDRATE EQUIVALENT TO PEMETREXED 100,0 mg | 100 mg/Vial | 560200.19756/26/0200.197 | Registered | S4 | None |
| Luprexta 500 mg/vial EACH VIAL CONTAINS PEMETREXED DISODIUM HEMIPENTAHYDRATE EQUIVALENT TO PEMETREXED 500,0 mg | 500 mg/Vial | 560201.19856/26/0201.198 | Registered | S4 | None |
| Luprexta 1 000 mg/vial EACH VIAL CONTAINS PEMETREXED DISODIUM HEMIPENTAHYDRATE EQUIVALENT TO PEMETREXED 1 000,0 mg | 000 mg 1/Vial | 560202.19956/26/0202.199 | Registered | S4 | None |
| Peminjo 100 inj EACH VIAL CONTAINS PEMETREXED DISODIUM EQUIVALENT TO PEMETREXED 100,0 mg | 100 | 56043456/26/0434 | Registered | S4 | None |
| Peminjo 500 inj EACH VIAL CONTAINS PEMETREXED DISODIUM EQUIVALENT TO PEMETREXED 500,0 mg | 500 | 56043556/26/0435 | Registered | S4 | None |
| Malihet 100 injection EACH VIAL CONTAINS PEMETREXED DISODIUM EQUIVALENT TO PEMETREXED 100,0 mg | 100Injection | 560436.43456/26/0436.434 | Registered | S4 | None |
| Malihet 500 injection EACH VIAL CONTAINS PEMETREXED DISODIUM EQUIVALENT TO PEMETREXED 500,0 mg | 500Injection | 560437.43556/26/0437.435 | Registered | S4 | None |
| Pesodin 100 injection EACH VIAL CONTAINS PEMETREXED DISODIUM EQUIVALENT TO PEMETREXED 100,0 mg | 100Injection | 560438.43456/26/0438.434 | Registered | S4 | None |
| Pesodin 500 injection EACH VIAL CONTAINS PEMETREXED DISODIUM EQUIVALENT TO PEMETREXED 500,0 mg | 500Injection | 560439.43556/26/0439.435 | Registered | S4 | None |
| Alimta 500 MG EACH VIAL CONTAINS PEMETREXED SODIUM EQUIVALENT TO PEMETREXED 500,0 mg | 500 mg | A390028A39/26/0028 | Registered | S4 | None |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Pemetrexed sodium equivalent to pemetrexed
S4: Pemetrexed
Consolidated Schedules 06 July 2026, line 7500
Pharmacological class: Cytostatic agents (class 26)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
Schedule Verification
Pexali 100, Macleods Pharmaceuticals SA (Pty) Ltd is scheduled S4 in its official SAHPRA documents, read with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.